Navigation Links
QLT announces Visudyne(R) sales for third quarter and provides Visudyne sales guidance for 2007
Date:10/17/2007

VANCOUVER, Oct. 18 /PRNewswire-FirstCall/ - QLT Inc. (NASDAQ:QLTI; TSX:QLT) today reported that Novartis AG announced global sales of QLT's Visudyne(R) (verteporfin) product of US$48.7 million for the quarter ended September 30, 2007. This represents a decrease of 35.1% over sales in the third quarter of 2006 and a 17.9% decline compared to the second quarter of 2007. Visudyne sales in the U.S. for the quarter were approximately US$9.4 million, representing 19.3% of total sales for the quarter. U.S. average daily Visudyne sales were 118 vials in the third quarter of 2007 compared to 122 vials in the second quarter of 2007.

The Company currently projects that total annual worldwide sales of Visudyne for 2007 will be in the range of US$210-$216 million.

"Visudyne average daily vial sales in the U.S. were relatively stable and in addition to the traditional seasonal weakness we experience in the third quarter, European sales declined due to increased trial of anti-VEGF drugs," said Bob Butchofsky, President and Chief Executive Officer of QLT Inc. "We continue to believe that Visudyne will remain an important part of treatment regimen for age-related macular degeneration (AMD) and are encouraged by the progress we are making in enrolling patients in our company sponsored clinical trial, known as 'RADICAL,' that is studying the use of Visudyne followed by an anti-VEGF agent with or without a steroid as compared to an anti-VEGF agent alone."

QLT will release its full financial results on Thursday, October, 25, 2007, at 7:30 a.m. Eastern Time (ET).

QLT Inc. is a global biopharmaceutical company dedicated to the discovery, development and commercialization of innovative therapies. Our research and development efforts are focused on pharmaceutical products in the fields of ophthalmology and dermatology. In addition, we utilize two unique technology platforms, photodynamic therapy and Atrigel(R), to create products such as Visudyne(R) and Eligar
'/>"/>

SOURCE QLT Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. PM announces a new health care order for India
2. Ramdoss Announces Introduction of RCH-II
3. Britain Announces Third Transfusion Related Mad Cow Case
4. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
5. Tibet Announces the Dalai Lama’s Tour of South Americ
6. NHS announces further Cost cutting Measures
7. Indian PM Announces Of Setting Up India Study Center At Tashkent
8. PowderMed Announces Needle-Less Flu Vaccine
9. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
10. Australian Government Announces Survey To Tackle Childhood Obesity
11. New Zealand Announces 10-year Plan For Betterment Of Mental Health Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... Up to 70% of Parkinson,s disease (PD) patients ... of life. Some patients have disturbed sleep/wake patterns ... while other patients may be subject to sudden ... PD patients may exhibit REM-sleep behavior disorder (RBD), ... even before motor symptoms appear. A review in ...
(Date:7/10/2014)... the human brain operates much the same whether active ... a better understanding of schizophrenia, bipolar disorder and other ... million Americans. , In newly published research in the ... at the Center for Molecular and Behavioral Neuroscience, determined ... rest is basically the same as that of a ...
(Date:7/10/2014)... Manchester scientists have shown that a new drug could prove ... aggressive form of lung cancer. , Scientists from the Cancer ... and part of the Manchester Cancer Research Centre, teamed up ... in 2010, to test a drug known as AZD3965 ... published in the journal Clinical Cancer Research , also ...
(Date:7/9/2014)... July 10, 2014 For the first time, researchers ... Aboriginal population in Canada uses health care. A new ... to clearly demonstrate the unique challenges faced by urban ... St. Michael,s Hospital. , The findings, published today ... urban First Nations individuals and the general population. , ...
(Date:7/9/2014)... hidden ways that cells are regulated, scientists at Rockefeller ... cells more likely to metastasize. , What,s more, the ... blocking two other proteins that are normally linked to ... could have unexpected ties. , The study, which ... , points to the possibility of new cancer therapies ...
Breaking Medicine News(10 mins):Health News:Sleep disturbances, common in Parkinson's disease, can be early indicator of disease onset 2Health News:Working to loosen the grip of severe mental illness 2Health News:New drug active against most aggressive type of lung cancer cells 2Health News:Urban Aboriginal people face unique health challenges 2Health News:Protein pushes breast cancer cells to metastasize 2Health News:Protein pushes breast cancer cells to metastasize 3
... Alzheimer's disease and is connected to the same brain pathology. There ... cognitive decline the loss of memory and certain other aspects of ... a normal part of aging, others that it is an early ... it's a disease in its own right. ,A new ...
... the combination of just two genes, according to a new study ... of Clinical Endocrinology and Metabolism this week,// identifies one gene on ... height in men. These genes may also help explain why men ... of both of these genes you will be taller than a ...
... serum concentrations of estrogen and testosterone have about twice ... relatively low serum concentrations of these sex hormones. Associations ... breast cancer were not different in women who donated ... levels in these women were not a preclinical finding. ...
... A new US research has found that young women are ... young men.The study, which contradicts the stereotype that men// are ... The Annals of Internal Medicine this week. ,Researchers from ... years after they were discharged from hospital after a heart ...
... the liver from damage, according to new research from ... laboratory rats. //The rats were then given D-galactosamine, a ... synthesis and results in cell death. The rats fed ... ,The Researchers discovered three new compounds that might ...
... drugs called statins may reduce their risk of developing ... to offer// powerful protection against heart disease for people ... evidence to date that statin drugs may also help ... smaller study had suggested these drugs might offer some ...
Cached Medicine News:
(Date:1/15/2014)... Jan. 15, 2014  Humberto C. Antunes,  Galderma  worldwide CEO, ... the Journal of Drugs in Dermatology (JDD) ... (ODAC). The event is January 17-20, 2014, at the Omni Orlando ... The ODAC is a distinguished event ...
(Date:1/15/2014)... Tegra Medical is very pleased to announce the appointment ... Chief Executive Officer.  Mark was promoted from his current role ... company,s four facilities in Massachusetts , ... Tegra Medical in 2012 with 20+ years of broad-based operations, ...
(Date:1/15/2014)... 15, 2014  According to Millennium Research Group (MRG), ... the United States and ... will expand moderately through 2022, with embolization particles ... increasing interest in drug-eluting beads (DEBs) and radioembolization ...
Breaking Medicine Technology:Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3
... St. Jude scientists, findings in ataxia telangiectasia-like ... into the links between brain disease and ... Tenn., Jan. 14 Scientists ... teased apart the biological details distinguishing two ...
... first quarterKENILWORTH, N.J., Jan. 14 Schering-Plough Corporation (NYSE: ... Food and Drug Administration (FDA) has issued a complete ... acute treatment of schizophrenia in adults and in the ... bipolar I disorder in adults as monotherapy. The ...
Cached Medicine Technology:Study Shows How Defective DNA Repair Triggers Two Neurological Diseases 2Study Shows How Defective DNA Repair Triggers Two Neurological Diseases 3U.S. FDA Issues Complete Response Letter for SAPHRIS(TM) (ASENAPINE) in the Acute Treatment of Both Schizophrenia and Bipolar I Disorder 2
A system for the removal and filtration of laser and surgical smoke....
The FreedomAire Surgical Helmet System is a lightweight, comfortable helmut system with superior air flow, and a removable motor module that lifts off for easy cleaning....
...
... contains these disposable, silver/silver chloride ... separated into eight tabs), two ... patient use only. Starter kit ... red and black, one green ...
Medicine Products: